1. Home
  2. GNSS vs VSTM Comparison

GNSS vs VSTM Comparison

Compare GNSS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$1.90

Market Cap

101.7M

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$5.64

Market Cap

470.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
VSTM
Founded
1992
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.7M
470.7M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
GNSS
VSTM
Price
$1.90
$5.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$4.75
$15.00
AVG Volume (30 Days)
131.3K
1.5M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
17.49
EPS
N/A
N/A
Revenue
$26,306,790.00
$30,914,000.00
Revenue This Year
$78.94
$254.18
Revenue Next Year
N/A
$99.39
P/E Ratio
N/A
N/A
Revenue Growth
29.50
209.14
52 Week Low
$1.46
$4.01
52 Week High
$2.70
$11.25

Technical Indicators

Market Signals
Indicator
GNSS
VSTM
Relative Strength Index (RSI) 47.07 41.19
Support Level $1.87 $5.56
Resistance Level $2.11 $6.66
Average True Range (ATR) 0.10 0.35
MACD 0.00 0.01
Stochastic Oscillator 48.90 14.95

Price Performance

Historical Comparison
GNSS
VSTM

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: